One of the more important agricultural technology disputes of the past few years was just settled, and I think the implications extend well beyond the two companies involved. Corteva and Inari reached a confidential agreement resolving a lawsuit Corteva filed in 2023 over Inari’s use of Corteva seed material and intellectual property. As part of the settlement, Inari agreed to destroy Corteva material it had accessed through seed depositories, destroy material developed from those deposits, assign Corteva intellectual property associated with edited versions of Corteva events, and negotiate certain licensing arrangements with Corteva.
The legal case itself was complicated, but the underlying business question is much easier to understand. Corteva argued that Inari, a much younger agricultural technology company built around advanced gene editing, had improperly used Corteva’s protected seed technology to help develop competing products. Inari disputed those claims and challenged portions of Corteva’s intellectual-property position. Court filings described the dispute as one between an established agricultural science company seeking to protect its seed technology and a newer entrant arguing that some of those protections were invalid or being used too aggressively.
What interests me isn’t deciding which side was right. The settlement takes care of that fight without giving us a full public resolution of every issue. What interests me is what the case tells us about where agricultural innovation is heading. For most of agriculture’s history, we thought about seed primarily as a physical product. You bought a bag of seed because somebody had developed genetics capable of producing more yield, resisting a disease or surviving a certain environment. Increasingly, however, the valuable asset inside that bag isn’t simply the seed itself. It’s the genetic information, the trait, the edit, the event and the legal right to use or modify those things.
That starts making agriculture look a lot more like the technology business. Think about software for a minute. The finished product somebody sees on a screen may be valuable, but enormous value sits underneath it in the code, patents, datasets, algorithms and intellectual property that allow the product to exist. Agriculture is moving toward something similar. Gene editing gives researchers the ability to make increasingly precise changes to plants, but the ability to make an edit doesn’t automatically mean you have the legal right to use every piece of genetic material necessary to make that edit commercially valuable.
That’s where this gets interesting for producers. We all want faster innovation. Farmers want hybrids and varieties that yield more, tolerate weather extremes, use nutrients more efficiently, resist disease and ultimately improve profitability. Startups can be incredibly good at developing new technologies quickly, and competition from younger companies can force established players to innovate faster. At the same time, companies such as Corteva spend enormous amounts of money and years of research developing genetics and traits. If those investments can simply be copied or modified by somebody else without compensation, the incentive to make those investments eventually declines.
The opposite risk also exists. If intellectual-property protections become so broad that new entrants can’t reasonably build on existing science, innovation can slow for a completely different reason. A company may have a superior editing technology or an entirely new idea but discover that much of the genetic foundation needed to commercialize it sits behind patents, licenses and contractual restrictions controlled by established companies. That doesn’t necessarily mean those protections are wrong, but it does mean the structure of intellectual property can influence who is capable of competing.
That’s why the Corteva-Inari settlement is bigger than a disagreement over a handful of seed deposits. Corteva specifically pointed to patent and plant-variety protection systems as important mechanisms for encouraging continued investment and competition in improved seed products. The company also emphasized that patent depositories serve a legitimate purpose by making biological materials accessible within defined legal rules. Inari’s agreement to destroy the Corteva material it accessed and assign intellectual property related to edited Corteva events reinforces how seriously ownership of the underlying genetic material is being treated.
Producers probably don’t need to understand every patent behind the seed they plant, but we should understand the direction this is going. As gene editing becomes more powerful, the economic value of agricultural innovation may increasingly shift away from simply owning physical assets and toward owning the genetic platforms and intellectual property sitting underneath them. The companies that control important traits, elite germplasm and the rights to modify them may have tremendous leverage over what gets developed next and who is allowed to develop it.
That also creates a strategic question for the entire agricultural industry. How do we protect the companies willing to invest billions of dollars developing better genetics while still leaving enough room for new competitors to enter the market and improve upon what already exists? Protect intellectual property too little and you weaken the incentive to innovate. Protect it too aggressively and you can make it extraordinarily difficult for the next generation of innovators to compete. Agriculture needs both the large companies capable of funding massive research programs and the startups willing to challenge how things have always been done.
I suspect this issue only gets more important from here. Gene editing, artificial intelligence and increasingly sophisticated biological research are going to make it possible to develop crops in ways we couldn’t imagine a generation ago. As that happens, one of the biggest fights in agriculture may no longer be over who owns the seed in the bag. It may be over who owns the genetic code underneath it, who is allowed to modify that code and who gets paid when the next breakthrough is built on top of something somebody else developed first. (Source: corteva.com, lawjustia.com)
